DK404588A - Tetrahydrocabazol-1-alkansyre og farmaceutisk praeparat indeholdende en saadan forbindelse - Google Patents

Tetrahydrocabazol-1-alkansyre og farmaceutisk praeparat indeholdende en saadan forbindelse

Info

Publication number
DK404588A
DK404588A DK404588A DK404588A DK404588A DK 404588 A DK404588 A DK 404588A DK 404588 A DK404588 A DK 404588A DK 404588 A DK404588 A DK 404588A DK 404588 A DK404588 A DK 404588A
Authority
DK
Denmark
Prior art keywords
tetrahydrocabazole
compound
pharmaceutical preparation
preparation containing
alkanic acid
Prior art date
Application number
DK404588A
Other languages
Danish (da)
English (en)
Other versions
DK404588D0 (da
Inventor
Yvan Guindon
John W Gillard
Christiane Yoakim
Yves Girard
Original Assignee
Merck Frosst Canada Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Frosst Canada Inc filed Critical Merck Frosst Canada Inc
Publication of DK404588D0 publication Critical patent/DK404588D0/da
Publication of DK404588A publication Critical patent/DK404588A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/86—Carbazoles; Hydrogenated carbazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Obesity (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
DK404588A 1987-07-21 1988-07-20 Tetrahydrocabazol-1-alkansyre og farmaceutisk praeparat indeholdende en saadan forbindelse DK404588A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/076,424 US4808608A (en) 1986-01-23 1987-07-21 Tetrahydrocarbazole 1-alkanoic acids, pharmaceutical compositions and use

Publications (2)

Publication Number Publication Date
DK404588D0 DK404588D0 (da) 1988-07-20
DK404588A true DK404588A (da) 1989-03-16

Family

ID=22131920

Family Applications (1)

Application Number Title Priority Date Filing Date
DK404588A DK404588A (da) 1987-07-21 1988-07-20 Tetrahydrocabazol-1-alkansyre og farmaceutisk praeparat indeholdende en saadan forbindelse

Country Status (10)

Country Link
US (1) US4808608A (ja)
EP (1) EP0300676A3 (ja)
JP (1) JPS6470462A (ja)
KR (1) KR890001987A (ja)
AU (1) AU611454B2 (ja)
DK (1) DK404588A (ja)
IL (1) IL87079A0 (ja)
NZ (1) NZ225361A (ja)
PT (1) PT88044B (ja)
ZA (1) ZA885209B (ja)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4940719A (en) * 1986-03-27 1990-07-10 Merck Frosst Canada, Inc. Tetrahydrocarbazole esters, pharmaceutical compositions and use
GB8924392D0 (en) * 1989-10-30 1989-12-20 Bayer Ag Substituted cycloalkano/b/dihydroindole-and-indolesulphonamides
US6300362B1 (en) 1990-07-25 2001-10-09 Novartis Ag (Formerly Sandoz Ltd.) Stabilized pharmaceutical compositions comprising acid donors
US5187180A (en) * 1990-07-26 1993-02-16 Merck Frosst Canada, Inc. (quinolin-2-ylmethoxy)heterotetrahydrocarbazoles as inhibitors of the biosynthesis of leukotrienes
US5221678A (en) * 1990-07-26 1993-06-22 Merck Frosst Canada, Inc. (quinolin-2-ylmethoxy)tetrahydrocarbazoles as inhibitors of the biosynthesis of leukotrienes
GB9101375D0 (en) * 1991-01-22 1991-03-06 Erba Carlo Spa N-imidazolyl derivatives of substituted tetrahydrocarbazole and cyclohepht(b)indole
US5230350A (en) * 1991-05-29 1993-07-27 Tabex Industries, Inc. Moisture barrier for indwelling catheters and the like
DE4435477A1 (de) 1994-10-04 1996-04-11 Bayer Ag Cycloalkano-indol- und -azaindol-derivate
US5830911A (en) * 1996-08-14 1998-11-03 American Home Products Corporation Pyranoindole and tetrahydrocarbazole inhibitors of COX-2
US20010047027A1 (en) * 2000-04-12 2001-11-29 Marc Labelle Prostaglandin D2 receptor antagonists
US6410583B1 (en) 2000-07-25 2002-06-25 Merck Frosst Canada & Co. Cyclopentanoindoles, compositions containing such compounds and methods of treatment
US7273883B2 (en) * 2000-09-14 2007-09-25 Allergan, Inc. Prostaglandin EP4 antagonist
US7217725B2 (en) * 2000-09-14 2007-05-15 Allergan, Inc. Prostaglandin D2 antagonist
AR038136A1 (es) 2002-01-24 2004-12-29 Merck Frosst Canada Inc Cicloalcanindoles con sustitucion con fluor composiciones que contienen estos compuestos y metodos de tratamiento
PL376440A1 (en) * 2002-10-30 2005-12-27 Merck Frosst Canada Ltd. Pyridopyrrolizine and pyridoindolizine derivatives
WO2004063156A1 (en) * 2003-01-08 2004-07-29 Biovitrum Ab Novel indole derivates as fabp-4 inhibitors
AR041089A1 (es) * 2003-05-15 2005-05-04 Merck & Co Inc Procedimiento y composiciones farmaceutiicas para tratar aterosclerosis, dislipidemias y afecciones relacionadas
WO2004103970A1 (en) * 2003-05-20 2004-12-02 Merck Frosst Canada Ltd. Fluoro-methanesulfonyl-substituted cycloalkanoindoles and their use as prostaglandin d2 antagonists
CN1805959A (zh) * 2003-06-12 2006-07-19 麦克弗罗斯特加拿大有限公司 作为dp拮抗剂的环烷吡咯并吡啶
JP4769718B2 (ja) * 2003-08-07 2011-09-07 メルク シャープ エンド ドーム リミテッド アルツハイマー病及び関連症状の治療
US7019022B2 (en) * 2003-12-15 2006-03-28 Merck Frosst Canada & Co. Substituted tetrahydrocarbazole and cyclopentanoindole derivatives
DK1725553T3 (da) * 2004-03-11 2008-08-18 Actelion Pharmaceuticals Ltd Tetrahydropyridoindolderivater
ES2369782T3 (es) 2004-12-27 2011-12-05 Actelion Pharmaceuticals Ltd. Derivados de 2,3,4,9-tetrahidro-1h-carbazol como antagonistas del receptor crth2.
US8076315B2 (en) 2005-10-14 2011-12-13 The Board Of Trustees Of The University Of Illinois Pharmacological treatments for sleep disorders (apnoe) with prostanoid receptor antagonists
KR101411820B1 (ko) * 2006-08-07 2014-06-24 액테리온 파마슈티칼 리미티드 (3-아미노-1,2,3,4-테트라하이드로-9ｈ-카르바졸-9-일)-아세트산 유도체
WO2008097535A2 (en) * 2007-02-08 2008-08-14 Merck & Co., Inc. Method of treating atherosclerosis, dyslipidemias and related conditions
EP2123273B1 (en) 2007-02-16 2013-10-23 ONO Pharmaceutical Co., Ltd. Therapeutic agent for urinary excretion disorder
BR112012024114B1 (pt) 2010-03-22 2021-02-09 Idorsia Pharmaceuticals Ltd Compostos derivados de 3-(heteroarilamino)-1,2,3,4-tetrahidro-9h-carbazol, uso dos mesmos, e, composição farmacêutica
AU2012241442B2 (en) 2011-04-14 2017-01-12 Idorsia Pharmaceuticals Ltd 7-(heteroaryl-amino)-6,7,8,9-tetrahydropyrido(1,2-a)indol acetic acid derivatives and their use as prostaglandin D2 receptor modulators
LT3119779T (lt) 2014-03-17 2018-09-10 Idorsia Pharmaceuticals Ltd Azaindolo acto rūgšties dariniai ir jų panaudojimas kaip prostaglandino d2 receptoriaus moduliatorių
TW201620909A (zh) 2014-03-18 2016-06-16 艾克泰聯製藥有限公司 氮雜吲哚乙酸衍生物及彼等作為前列腺素ｄ２受體調節劑之用途
MX2018003202A (es) 2015-09-15 2018-06-08 Idorsia Pharmaceuticals Ltd Formas cristalinas.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3896145A (en) * 1972-07-24 1975-07-22 Hoffmann La Roche Carbazoles
US4009181A (en) * 1973-01-22 1977-02-22 Hoffmann-La Roche Inc. Cyclopenta[b]indole-2-carboxylic acids and derivatives thereof
US4057559A (en) * 1973-10-01 1977-11-08 American Home Products Corporation Carbazole acetic acid derivatives
IL81325A (en) * 1986-01-23 1990-11-29 Merck Frosst Canada Inc Tetrahydrocarbazole 1-alkanoic acids and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
DK404588D0 (da) 1988-07-20
AU611454B2 (en) 1991-06-13
IL87079A0 (en) 1988-12-30
PT88044B (pt) 1995-03-01
ZA885209B (en) 1989-03-29
US4808608A (en) 1989-02-28
NZ225361A (en) 1991-06-25
JPS6470462A (en) 1989-03-15
EP0300676A3 (en) 1991-07-03
KR890001987A (ko) 1989-04-07
EP0300676A2 (en) 1989-01-25
AU1926288A (en) 1989-01-27
PT88044A (pt) 1989-06-30

Similar Documents

Publication Publication Date Title
DK404588A (da) Tetrahydrocabazol-1-alkansyre og farmaceutisk praeparat indeholdende en saadan forbindelse
DK314789A (da) Quinolinetheralkansyre og farmaceutisk praeparat indeholdende en saadan forbindelse
DK284485A (da) Indol-2-alkansyre og farmaceutisk praeparat indeholdende en saadan forbindelse
DK655288A (da) Diarylstyrylquinolindisyre og farmaceutisk praeparat indeholdende en saadan forbindelse
DK406389A (da) Thiazolo(4,5,d)pyrimidinforbindelse og farmaceutisk praeparat indeholdende en saadan forbindelse
DK85985A (da) Carbamoyl- eller acyl-4-aza-5alfa-androst-1-en-3-on og farmaceutisk praeparat indeholdende en saadan forbindelse
DK287085D0 (da) Triazolobenzodiazepin og farmaceutisk praeparat indeholdende en saadanforbindelse
DK224589D0 (da) Polymalonsyreforbindelse og farmaceutisk praeparat indeholdende en saadan forbindelse
DK287188A (da) Cephalosporinforbindelser og farmaceutisk praeparat deraf
DK48886A (da) Akryl- eller heteroarylforbindelse og farmaceutisk praeparat indeholdende en saadan forbindelse
DK537288A (da) Tetrahydrocarbazolester og farmaceutisk praeparat indeholdende en saadan forbindelse
DK375584D0 (da) Piperidinoquinazolinforbindelser og farmaceutisk praeparat indeholdene en saadan forbindelse
DK48790A (da) Steroidforbindelse og farmaceutisk praeparat indeholden en saadan forbindelse
DK314386A (da) Quinoloncarboxyylsyreforbindelse og antibakterielle farmaceutiske praeparater indeholdende denne
DK23088A (da) Piperazinylpyrimidinforbindelse og farmaceutisk praeparat indeholdende en saadan forbindelse
DK191787D0 (da) Carbapenemforbindelse og farmaceutisk praeparat indeholdende en saadan forbindelse
DK680787D0 (da) Farmaceutisk praeparat indeholdende en pyranoquinolinforbindelse
DK258086D0 (da) Substitueret hexahydroarylquinolin og farmaceutisk praeparat indeholdende en saadan forbindelse
DK404488A (da) Cyclohept(b)indolalkansyre og farmaceutisk praeparat indeholdende en saadan forbindelse
DK60187A (da) Bis-diozopiperazin-derivater og laegemiddelformuleringer indeholdende saadanne forbindelser
DK669287D0 (da) Farmaceutisk praerarat indeholdende en pyranoquinolinforbindelse
DK330389D0 (da) Tetrahydropyranonforbindelse og farmaceutisk praeparat indeholdende en saadan forbindelse
DK513588D0 (da) Thieno(2,3-b)furan-2-sulfonamid og farmaceutisk praeparat indeholdende en saadan forbindelse
DK153842C (da) Dihydrodibenzotiepinderivat og farmaceutisk praeparat indeholdende det
DK155006C (da) Kondenserede imidazolderivater og farmaceutisk praeparat indeholdende en saadan forbindelse

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment